Drug developers aren’t expected to come back to the US equity markets in full force until next year — lagging other ...

ZURICH, SWITZERLAND, May 29, 2025 -- VERAXA Biotech AG (“VERAXA”), an emerging leader in designing novel cancer therapies and proposed de-SPAC acquisition target of Voyager Acquisition Corp.

Genscript Biotech ( ($HK:1548) ) just unveiled an announcement. Genscript Biotech Corporation held its Annual General Meeting on May 29, 2025, ...

The UK biotech was outperforming the broader market before COVID-19 hit and since then its relative performance has been stronger and there have been new investors entering the sector on the ...

A disconnect between upstream and downstream work continues to hold back progress in biomanufacturing, claims the CEO of ...

The industrial and energy segments saw a strong representation, with Inox Wind, PTC Industries, AstraZeneca Pharma, Inox Wind ...

Inc. , (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced the appointment of Brandi L.

The installation was finalized during Q1 2025 and supports critical pharmaceutical storage and cold chain logistics operations. This deployment represents the continuation of a multi-year relationship ...

With Boster Bio's latest promotion, scientists globally enjoy free access to antibody validation to boost research accuracy.

Healthpeak’s development projects across its life science portfolio should be completed at development yields above the company's weighted average cost of capital and could drive strong internal ...

Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Small Cap Growth Fund” first quarter ...

Ailsa Craig and Marek Poszepczynski, portfolio managers at the International Biotechnology Trust, tell MoneyWeek where they’d ...